Browse all articles

Home Get the app

Head to head Published May 5, 2026

Uridine 5'-Monophosphate vs Triacetyluridine for cognitive and mood support

This choice matters if you want a daily supplement that fits a simple stack versus a form that pushes uridine into the blood faster and with prescription grade labeling. The tradeoff is between easier, lower cost wellness use and a product with stronger pharmacology but thinner routine supplement evidence.

Evidence: preliminary 9 criteria 10 sources

Evidence summary

Evidence summary

For daily cognitive support and value, UMP is the better pick; for the fastest blood-uridine rise, TAU is the other choice.

  • Across 1 long trial (n=311), a UMP-containing multinutrient slowed cognitive decline in prodromal Alzheimer's disease, below the noticeable-change threshold.4
  • TAU wins on fastest blood-uridine rise and prescription-grade standardization, which suits people prioritizing pharmacology over daily supplement value.1
  • TAU’s mood-support signal comes from a small bipolar study, so routine wellness use rests on thin evidence.3

The contenders

Two ways to approach the same goal

Option A

Uridine 5'-Monophosphate (UMP)

Standardization

Usually sold as uridine 5'-monophosphate, often as a disodium salt in capsules or powder. In the Fortasyn Connect medical food formula, the daily 125 mL serving provides 625 mg UMP alongside docosahexaenoic acid, eicosapentaenoic acid, choline, phospholipids, B vitamins, vitamin C, vitamin E, and selenium.

Forms

Capsules, tablets, bulk powder, and multi-nutrient medical food formulas that combine UMP with omega 3 fats and choline.

Typical dosage

Common retail use is roughly 150 to 500 mg per day, while the best studied cognitive nutrition formula uses 625 mg UMP per day as part of a multi-nutrient drink. A registered adolescent bipolar depression trial used oral uridine 500 mg twice daily for 6 weeks, but this was uridine as the active intervention, not an over the counter UMP cognition protocol.

Strengths

  • Best fit for everyday supplement use because it is widely available, inexpensive, and commonly sold in capsule or powder form.
  • Has the most relevant human cognitive nutrition evidence when used as part of a multi-nutrient formula with omega 3 fats and choline. In prodromal Alzheimer's disease, the 36 month LipiDiDiet trial reported less decline on several cognitive and functional measures versus control, although this does not prove UMP alone caused the effect.
  • Works well in stack-based approaches because UMP, choline, and omega 3 fats are all building blocks used to make cell membranes, which are the outer layers and connection surfaces of brain cells.

Trade-offs

  • Human evidence for UMP by itself in healthy adults seeking sharper focus or better mood is limited. The stronger cognition data come from combined formulas, so the benefit cannot be assigned to UMP alone.
  • Effects, if any, are likely gradual rather than same-day. Cognitive nutrition trials generally measured outcomes over weeks to years, not hours.
  • Supplement quality can vary because UMP products are dietary supplements, not prescription drugs with a Food and Drug Administration drug label.

Safety

No UMP-specific prescription label exists for cognitive support. Practical caution is warranted for pregnancy, breastfeeding, bipolar disorder, active cancer treatment, and use with complex medication regimens because the strongest safety data are not from long-term UMP-alone trials in healthy supplement users.138

Option B

Triacetyluridine (Uridine Triacetate, TAU)

Vistogard and Xuriden are prescription uridine triacetate products in the United States; triacetyluridine is also sold by some supplement vendors as TAU.

Standardization

Prescription uridine triacetate is an acetylated prodrug of uridine. A prodrug is a form the body converts into the active molecule. Vistogard oral granules are listed as 95 percent weight by weight and supplied in 10 gram packets.

Forms

Prescription oral granules. Some nonprescription niche products sell TAU capsules or powder, but the strongest standardization data are for prescription products.

Typical dosage

For the prescription rescue product Vistogard, adults receive 10 grams by mouth every 6 hours for 20 doses after fluorouracil or capecitabine overdose or early severe toxicity. For hereditary orotic aciduria, Xuriden labeling starts at 60 mg per kg once daily and can increase to 120 mg per kg, up to 8 grams daily. A small open-label bipolar depression study used up to 18 grams per day for 6 weeks. These are medical or research doses, not routine wellness doses.

Strengths

  • Produces much higher systemic uridine exposure than oral uridine at the same molar amount. Drug references and pharmacokinetic work report roughly 4 to 6 times higher exposure versus equimolar uridine in humans, with peak levels usually in 2 to 3 hours.
  • Has a direct small human mood signal. In an open-label study of 11 adults with bipolar depression, up to 18 grams per day for 6 weeks was associated with lower depression scale scores and brain energy chemistry changes, but the study had no placebo group.
  • Prescription forms have clearer identity, potency, storage, and adverse event labeling than typical supplement products.

Trade-offs

  • Not well matched to routine wellness buying. The Food and Drug Administration approved prescription use is for emergency rescue after fluorouracil or capecitabine overdose or early severe toxicity, and for hereditary orotic aciduria, not cognitive enhancement.
  • Usually costs far more per gram of delivered uridine than UMP in the supplement market, and prescription products are designed for rare medical uses rather than daily nootropic use.
  • Mood evidence is preliminary. The main adult bipolar depression study had only 11 participants, was open-label, and used high doses under research supervision.

Safety

Prescription uridine triacetate labeling lists no contraindications or warnings for Vistogard, but common adverse reactions above 2 percent include vomiting, nausea, and diarrhea. The label also warns that it may reduce the effectiveness of fluorouracil or capecitabine if used outside the emergency setting.1

Head-to-head

How they compare, criterion by criterion

Everyday cognitive support evidence

Winner: A · Uridine 5'-Monophosphate (UMP)

Importance: high

UMP appears in Fortasyn Connect, a multi-nutrient formula studied in several randomized trials. The 36 month LipiDiDiet trial in 311 people with prodromal Alzheimer's disease reported less decline on a 5 item cognitive composite, memory, clinical function, and brain atrophy measures versus control. This supports the UMP-containing formula, not UMP alone, but it is still more relevant to cognition buyers than TAU's prescription rescue evidence.45

Mood support evidence

Winner: B · Triacetyluridine (Uridine Triacetate, TAU)

Importance: high

TAU has the more direct human mood signal: an open-label 6 week study in 11 adults with bipolar depression used up to 18 grams per day and reported lower Montgomery Asberg Depression Rating Scale scores. UMP has an adolescent uridine trial signal and case series context, but the evidence is still small and not a direct UMP versus TAU supplement comparison.37

Bioavailability and onset

Winner: B · Triacetyluridine (Uridine Triacetate, TAU)

Importance: high

TAU is a prodrug that the body converts to uridine and provides about 4 to 6 times more systemic uridine exposure than equal-molar oral uridine, with peak uridine levels generally reached in 2 to 3 hours. UMP is usable orally, but it is not the winner when the goal is rapid, high blood uridine exposure.19

Dose practicality

Winner: A · Uridine 5'-Monophosphate (UMP)

Importance: high

UMP is commonly used in capsule or powder doses in the hundreds of milligrams, and the studied Fortasyn Connect formula provides 625 mg UMP per daily serving. TAU research and prescription dosing often uses gram-level amounts, such as 10 grams every 6 hours for Vistogard rescue dosing or up to 18 grams per day in the small bipolar depression study, which is not practical for routine wellness use.1356

Standardization and quality control

Winner: B · Triacetyluridine (Uridine Triacetate, TAU)

Importance: medium

Prescription TAU products have formal labeling, defined dosage forms, storage information, and adverse reaction reporting. UMP supplements can be legitimate, but as dietary supplements they do not carry the same drug-label standardization or indication-specific safety review.128

Side effects and tolerability

Winner: Tie · Either option

Importance: high

Vistogard labeling reports vomiting, nausea, and diarrhea as adverse reactions occurring in more than 2 percent of patients, while the S-Connect trial of a UMP-containing medical food reported no group differences in adverse event rates and no clinically relevant blood safety differences over 24 weeks. These are different populations and products, so neither form clearly wins for all users.110

Cost and value per daily use

Winner: A · Uridine 5'-Monophosphate (UMP)

Importance: high

UMP wins for value because it is widely sold as a simple supplement and is used at hundreds of milligrams per day. Prescription TAU products are packaged and dosed for rare medical indications, such as 10 gram Vistogard packets for emergency rescue, which makes them a poor value match for routine cognitive support.15

Stacking with omega 3 and choline

Winner: A · Uridine 5'-Monophosphate (UMP)

Importance: medium

The best-known cognitive nutrition approach combines UMP with docosahexaenoic acid, eicosapentaenoic acid, choline, phospholipids, and vitamins to support membrane formation. This gives UMP a clearer role in a structured stack, while TAU's main advantage is delivery of uridine rather than evidence as part of a long-term wellness stack.56

Drug interaction clarity

Winner: B · Triacetyluridine (Uridine Triacetate, TAU)

Importance: medium

TAU has clearer interaction language from drug references: clinically important cytochrome P450 enzyme interactions are considered unlikely, but there is a possible interaction with orally administered P-glycoprotein substrates such as digoxin, and it can reduce the intended effect of fluorouracil or capecitabine. UMP supplement labels usually provide less formal interaction detail.12

Which should you choose

By goal and use case

You want a daily cognitive support supplement and plan to stack with fish oil or choline

Choose A · Uridine 5'-Monophosphate (UMP)

UMP is the more practical fit because human cognitive nutrition trials used UMP inside a formula with omega 3 fats and choline, and common UMP dosing is in a manageable capsule range. The evidence is not proof that UMP alone sharpens focus, but it is the more relevant option for this buying goal.456

You want the strongest and fastest rise in blood uridine

Choose B · Triacetyluridine (Uridine Triacetate, TAU)

TAU wins because it is designed as a more absorbable uridine prodrug and reaches peak uridine levels in about 2 to 3 hours, with about 4 to 6 times higher exposure than equal-molar oral uridine.19

You are comparing options for mood support and have a bipolar history

Choose Tie · Either option

TAU has a small open-label adult bipolar depression study, and uridine has small adolescent bipolar depression data, but this is a medical scenario rather than a casual supplement decision. People with bipolar disorder should involve a clinician because mood-elevating or energizing supplements can be risky when mood is unstable.37

You want the lowest cost per realistic daily serving

Choose A · Uridine 5'-Monophosphate (UMP)

UMP is the clear value pick because it is widely available as a supplement in hundreds-of-milligrams doses. TAU's best standardized products are prescription drugs intended for rare or emergency uses, not economical daily wellness routines.15

You are currently taking fluorouracil or capecitabine, or you recently had chemotherapy toxicity

Choose B · Triacetyluridine (Uridine Triacetate, TAU)

This is not a supplement-shopping situation. Prescription uridine triacetate is specifically labeled for emergency treatment after fluorouracil or capecitabine overdose or early severe toxicity within 96 hours, but it should be directed by oncology care because it may reduce the effectiveness of those medicines if used outside the emergency setting.12

You want the cleanest regulated identity and potency documentation

Choose B · Triacetyluridine (Uridine Triacetate, TAU)

Prescription TAU products have formal drug labeling and defined granule strength. UMP products vary by supplement manufacturer, so buyers need to rely on third-party testing and transparent labeling rather than a drug label.18

The bottom line

For most health-conscious readers, UMP is the better buy for cognitive and general mood support because it is easier to dose, cheaper, more available, and appears in the best human cognitive nutrition trials, even though those trials tested multi-nutrient formulas rather than UMP alone.456 TAU wins on pharmacokinetics, meaning it gets more uridine into the blood faster, and it has a small open-label bipolar depression signal, but that does not make it the better everyday nootropic because its strongest clinical role is prescription rescue or replacement therapy, not wellness supplementation.1239

Safety considerations

Do not use either form as a substitute for medical care for depression, cognitive decline, chemotherapy toxicity, or inherited metabolic disorders. TAU has prescription safety data, but Vistogard's common adverse reactions include vomiting, nausea, and diarrhea, and it is not recommended for non-emergency management of fluorouracil or capecitabine adverse reactions because it may reduce those medicines' intended effect.12 TAU may also interact with some orally administered P-glycoprotein substrates such as digoxin, so medication users should ask a pharmacist or clinician before use.2 For UMP, the main caution is evidence quality: long-term UMP-alone safety data for healthy nootropic users are not robust, and the most relevant cognitive studies used a multi-nutrient medical food rather than isolated UMP.4510

Frequently asked

Common questions

Is UMP the same thing as uridine?

No. UMP is uridine with a phosphate group attached. During digestion and metabolism, it can contribute to the body's uridine pool, but product dose labels are not interchangeable milligram for milligram with free uridine or TAU.

Can I combine UMP with citicoline?

Be cautious. Citicoline can also raise uridine-related metabolites and supplies choline, so combining it with UMP may be redundant for some users. Start low and avoid stacking many cholinergic products at once if you are prone to headaches, low mood, irritability, or sleep disruption.

Does TAU work better than UMP at a lower dose?

TAU is more efficient at raising blood uridine than oral uridine, but there is no high-quality head-to-head trial showing that low-dose TAU gives better cognitive or mood outcomes than UMP in healthy adults.

How long should someone trial UMP for cognitive support?

If used at all, think in weeks rather than days. The better human cognition data for UMP-containing formulas measured outcomes over 24 months to 36 months in prodromal Alzheimer's disease, while supplement users often trial UMP for 8 to 12 weeks before judging subjective benefit.

Which form is better for people who dislike powders?

UMP is usually easier because many brands sell small capsules in common daily serving sizes. Prescription TAU granules and niche TAU powders are less convenient for routine wellness use.

Sources

  1. 1. DailyMed. VISTOGARD, uridine triacetate granule, prescribing information (2026) FDA drug label via DailyMed ↑
  2. 2. Drugs.com. Uridine Triacetate Monograph for Professionals (2026) Professional drug monograph ↑
  3. 3. Jensen JE et al. Triacetyluridine decreases depressive symptoms and increases brain pH in bipolar patients (2008) Clinical trial, open-label ↑
  4. 4. Soininen H et al. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease (2021) Randomized, double-blind, placebo-controlled trial ↑
  5. 5. Nutricia Souvenaid. Composition of Souvenaid and Fortasyn Connect (2026) Manufacturer composition page ↑
  6. 6. Scheltens P et al. The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease (2014) Randomized controlled trial ↑
  7. 7. ClinicalTrials.gov. Uridine Adolescent Bipolar Depression Randomized Controlled Trial, NCT01805440 results (2017) Clinical trial registry results ↑
  8. 8. FDA. Dietary Supplement Products and Ingredients (2025) Regulatory guidance ↑
  9. 9. Dudley E et al. Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement (2011) Pharmacokinetic study ↑
  10. 10. Scheltens P et al. The S-Connect study, safety and adverse event results (2014) Randomized controlled trial ↑

Want personalized recommendations?

Show me what works for me